Global Phototherapy Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Devices;
Firefly, Fiber-Optic Blanket, Fiber-Optic Band, and Others.By Application;
UVA, UVB, and UVC.By Indication;
Skin Diseases, Jaundice, and Others.By End User;
Hospitals & Clinics, Dermatology Center, Homecare, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Phototherapy Market (USD Million), 2021 - 2031
In the year 2024, the Global Phototherapy Market was valued at USD 439.10 million. The size of this market is expected to increase to USD 591.57 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.4%.
The global phototherapy market, a cornerstone in the realm of medical treatment, is experiencing a profound evolution, fueled by advancements in technology and a deepening understanding of light's therapeutic properties. Phototherapy, a form of medical intervention employing specific wavelengths of light to treat various conditions, has garnered significant attention across diverse medical disciplines, ranging from dermatology to neonatology.
This market's growth trajectory is underpinned by several key factors, including rising incidences of skin disorders such as psoriasis, eczema, and vitiligo, along with an increasing prevalence of neonatal jaundice worldwide. Additionally, the growing geriatric population, coupled with the expanding adoption of phototherapy in cosmetic procedures, further propels market expansion.
Innovative product developments, such as LED-based phototherapy devices offering enhanced efficacy and safety profiles, are driving market competitiveness and fostering a conducive environment for market proliferation. Furthermore, the integration of advanced technologies like artificial intelligence and IoT into phototherapy systems is poised to revolutionize treatment modalities, providing personalized and optimized therapeutic outcomes.
Geographically, North America and Europe stand as dominant players in the global phototherapy market, owing to robust healthcare infrastructure, high healthcare expenditure, and a strong presence of leading market players. However, burgeoning economies in Asia-Pacific and Latin America are witnessing rapid market growth, propelled by increasing healthcare expenditure, improving healthcare infrastructure, and a growing awareness regarding the benefits of phototherapy.
Despite these promising prospects, challenges such as stringent regulatory frameworks, reimbursement issues, and the high cost associated with phototherapy equipment pose significant hurdles to market growth. Nevertheless, strategic collaborations, mergers, and acquisitions among key market players, along with a relentless focus on research and development, are anticipated to overcome these challenges and foster sustainable market expansion.
Global Phototherapy Market Recent Developments
-
In November 2021, Little Sparrows Technologies, a U.S.-based tech firm, gained FDA approval for its bili-hut, a home phototherapy device designed to treat newborns with jaundice. This innovative solution not only lowers medical costs but also enables infants to recover alongside their families during treatment. The bili-hut offers high-intensity light therapy comparable to that found in NICUs and is portable, foldable, lightweight, and energy-efficient, running on batteries, making it suitable for various environments, including hospitals and rural or resource-limited areas
-
In September 2022, Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration (FDA) granted approval for Sotyktu (deucravacitinib), an oral medication indicated for the treatment of moderate to severe plaque psoriasis in adults.
Segment Analysis
The global phototherapy market is a multifaceted industry that has been segmented to provide detailed insights into various aspects influencing its growth and application. One of the primary ways the market is segmented is by the type of devices used. Phototherapy devices vary from handheld units and overhead light panels to more sophisticated full-body units, each designed to cater to different therapeutic needs. These devices harness various types of light and radiation to achieve optimal treatment outcomes, which range from managing skin conditions to addressing mood disorders.
The market is also segmented by radiation type, which can include ultraviolet (UV) light, visible light, and even blue light, each having specific therapeutic benefits. Ultraviolet (UV) light, further broken down into UVA, UVB, and UVC, plays a significant role in treating skin disorders like psoriasis, vitiligo, and neonatal jaundice. Visible light and blue light are often utilized for conditions such as acne and certain types of mood disorders, capitalizing on their ability to penetrate the skin or influence biological processes that can alter psychological well-being. Each type of radiation offers a unique set of benefits, leading to tailored treatment protocols based on the patient's condition.
Segmentation by indication focuses on the conditions treated through phototherapy. This can include dermatological conditions such as psoriasis, eczema, acne, and vitiligo, as well as non-dermatological uses like treating mood disorders, particularly Seasonal Affective Disorder (SAD). Phototherapy's efficacy in managing these conditions has been well-documented, contributing to its increased adoption in clinical settings. The choice of indication often determines the type of device and radiation applied, ensuring that the therapy meets specific treatment goals.
The market is also segmented by end user, highlighting the various entities that utilize phototherapy. This includes hospitals, clinics, dermatology centers, and home care settings, each requiring different types of equipment and treatment plans. Hospitals and specialized clinics are typically equipped with advanced phototherapy units capable of handling a higher volume of patients and providing comprehensive care. In contrast, home care settings may use more compact and portable devices designed for individual use, providing a convenient way for patients to manage their conditions outside of clinical environments.
Lastly, geography plays a role in shaping the global phototherapy market, as different regions have unique healthcare needs, regulatory standards, and levels of technological adoption. Developed regions, such as North America and Europe, often have a more extensive market presence due to advanced healthcare infrastructure and higher awareness of phototherapy's benefits. Conversely, emerging regions may be experiencing growth driven by improving healthcare access and increasing medical infrastructure.
Global Phototherapy Segment Analysis
In this report, the Global Phototherapy Market has been segmented by Devices, Radiation, Indication, End User and Geography.
Global Phototherapy Market, Segmentation by Devices
The Global Phototherapy Market has been segmented by Devices into Firefly, Fiber-Optic Blanket, Fiber-Optic Band and Others.
One prominent device in this landscape is the Firefly, renowned for its compact and portable design. Firefly devices deliver targeted phototherapy, primarily utilized in dermatological settings for treating skin conditions like psoriasis and eczema. Their versatility and ease of use make them valuable assets in both hospital environments and outpatient clinics, providing patients with efficient and convenient treatment options.
Another notable segment within the phototherapy device market is the Fiber-Optic Blanket. These blankets offer a gentle yet effective solution for managing neonatal jaundice, a common condition in newborns characterized by elevated bilirubin levels. Fiber-Optic Blankets utilize specialized fibers to deliver therapeutic light directly to the infant's skin, facilitating the breakdown of excess bilirubin and reducing the need for invasive interventions. Their soft and flexible design ensures optimal comfort for newborns while enabling healthcare providers to monitor and adjust treatment as needed.
The market encompasses Fiber-Optic Bands, which provide localized phototherapy for dermatological applications. These bands are designed to deliver precise doses of therapeutic light to specific areas of the skin, making them ideal for treating conditions such as vitiligo and localized psoriasis. Their flexibility and adaptability allow for customized treatment regimens tailored to each patient's unique needs, enhancing therapeutic outcomes and patient satisfaction.
Global Phototherapy Market, Segmentation by Radiation
The Global Phototherapy Market has been segmented by Radiation into UVA, UVB, and UVC.
UVA light, which has the longest wavelength range from 320 to 400 nm, is primarily used in applications where deep tissue penetration is necessary. In the medical and cosmetic fields, UVA is commonly utilized for phototherapy treatments to manage conditions like psoriasis, eczema, and vitiligo. This type of UV light can penetrate the skin deeper than UVB or UVC, making it effective for therapeutic procedures aimed at stimulating specific responses in the skin. Additionally, UVA is used in tanning beds and for certain laboratory studies where deeper skin penetration is needed to observe biological or chemical processes. In industrial settings, UVA is used in the curing and drying of coatings, inks, and adhesives due to its ability to trigger chemical reactions that promote quick drying and solidification.
UVB light, which has a shorter wavelength (290 to 320 nm), is more intense and energetic than UVA, making it highly effective for specific applications. It is most commonly associated with the body's production of vitamin D, essential for bone health and metabolic function. In the medical realm, UVB is utilized for phototherapy as it helps in treating skin diseases such as psoriasis, dermatitis, and jaundice, facilitating skin healing and immune response regulation. Due to its ability to destroy microorganisms, UVB is also employed in surface sterilization, water treatment, and air purification systems, contributing to enhanced hygiene in hospitals, laboratories, and public facilities. However, prolonged exposure to UVB light can damage the skin and increase the risk of skin cancer, making it crucial to use protective measures during its application.
UVC light has the shortest wavelength (100 to 290 nm) and is known for its potent germicidal properties. UVC is primarily used for disinfection and sterilization because it can effectively inactivate bacteria, viruses, and other pathogens by damaging their DNA or RNA. This type of UV light is widely used in water purification systems, air sterilizers, and surface disinfection devices, ensuring that environments meet health and safety standards. UVC is highly effective for sanitation in hospitals, laboratories, food processing plants, and other settings that require high levels of hygiene. Unlike UVA and UVB, UVC does not naturally reach the Earth's surface as it is absorbed by the ozone layer. This characteristic makes UVC light a specialized tool for controlled disinfection processes rather than a naturally occurring source of UV radiation.
Global Phototherapy Market, Segmentation by Indication
The Global Phototherapy Market has been segmented by Indication into Skin Diseases, Jaundice and Others.
One key segment within this framework is skin diseases, which include dermatological conditions such as psoriasis, eczema, vitiligo, and atopic dermatitis. Phototherapy has emerged as a cornerstone treatment modality for these conditions, offering targeted light therapy to alleviate symptoms, reduce inflammation, and promote skin healing. With its proven efficacy and minimal side effects, phototherapy continues to be a preferred choice for patients and healthcare providers alike in managing various skin diseases.
Another significant segment in the phototherapy market is jaundice, particularly neonatal jaundice, a common condition affecting newborns worldwide. Elevated bilirubin levels in newborns can lead to jaundice, posing risks of neurological complications if left untreated. Phototherapy, through its ability to break down excess bilirubin in the skin, serves as a crucial intervention for managing neonatal jaundice, preventing severe complications and ensuring the healthy development of newborns. Fiber-Optic Blankets and specialized phototherapy devices are specifically designed for neonatal jaundice treatment, providing gentle and effective light therapy to newborns in hospital settings.
Beyond these primary indications, the phototherapy market encompasses a range of other medical conditions where light-based interventions demonstrate therapeutic benefits. These may include conditions such as mood disorders like seasonal affective disorder (SAD), certain types of cancer, and wound healing, among others. The versatility of phototherapy extends its applications across diverse medical specialties, contributing to its continued growth and adoption in healthcare settings worldwide.
Global Phototherapy Market, Segmentation by End User
The Global Phototherapy Market has been segmented by End User into Hospitals & Clinics, Dermatology Center, Homecare and Others.
One primary segment within this framework is hospitals and clinics, which serve as the frontline for delivering phototherapy treatments across various medical specialties. Equipped with specialized phototherapy devices and staffed by trained healthcare professionals, hospitals and clinics offer comprehensive care to patients requiring light-based interventions for conditions such as skin diseases, neonatal jaundice, and mood disorders.
Dermatology centers represent another significant segment in the phototherapy market, focusing specifically on the diagnosis and treatment of dermatological conditions. These specialized facilities offer dedicated phototherapy services tailored to address skin disorders such as psoriasis, eczema, vitiligo, and acne. Dermatology centers often feature advanced phototherapy equipment and expertise, providing patients with specialized care and personalized treatment regimens to achieve optimal outcomes.
Homecare settings play a crucial role in the phototherapy market, catering to patients who require ongoing treatment outside of traditional healthcare facilities. With the advent of portable and user-friendly phototherapy devices, patients can receive light-based treatments in the comfort of their own homes, under the guidance of healthcare professionals or caregivers. Home phototherapy services offer convenience, flexibility, and improved patient compliance, particularly for individuals with chronic skin conditions or neonatal jaundice requiring long-term management.
Other end users such as specialized treatment centers, research institutions, and aesthetic clinics contribute to the multifaceted landscape of phototherapy utilization. These settings may focus on niche applications of phototherapy, such as cancer treatment, wound healing, or cosmetic procedures, leveraging light-based interventions to address specific patient needs and advance medical research.
Global Phototherapy Market, Segmentation by Geography
In this report, the Global Phototherapy Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Phototherapy Market Share (%), by Geographical Region, 2024
The global phototherapy market is segmented by geography, reflecting the regional variations in market dynamics, healthcare infrastructure, and patient demographics. North America stands out as a significant market segment, characterized by its robust healthcare system, high healthcare expenditure, and a strong presence of leading market players. The region's advanced medical facilities and widespread adoption of innovative technologies drive substantial demand for phototherapy interventions across various medical specialties, including dermatology, neonatology, and psychiatry.
Europe represents another prominent segment in the global phototherapy market, leveraging its well-established healthcare infrastructure and stringent regulatory standards to ensure the quality and safety of phototherapy treatments. With a growing prevalence of skin diseases and neonatal jaundice, coupled with increasing healthcare awareness, European countries witness significant utilization of phototherapy devices in hospitals, clinics, and specialized treatment centers.
Asia-Pacific emerges as a rapidly growing market segment for phototherapy, fueled by expanding healthcare infrastructure, rising healthcare expenditure, and a burgeoning patient population. Countries such as China, India, and Japan lead the region's market growth, driven by increasing incidences of skin disorders, neonatal jaundice, and a growing demand for aesthetic procedures. The availability of cost-effective phototherapy solutions and the adoption of innovative technologies contribute to the region's burgeoning phototherapy market.
Latin America and the Middle East & Africa represent emerging market segments in the global phototherapy landscape, characterized by improving healthcare infrastructure, rising disposable incomes, and a growing focus on healthcare quality and accessibility. While these regions face unique challenges such as healthcare disparities and regulatory hurdles, the increasing prevalence of skin diseases, neonatal jaundice, and other medical conditions underscores the growing demand for phototherapy interventions as part of comprehensive healthcare services.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Phototherapy Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers :
- Technological Advancements
- Rising Incidence of Skin Disorders
- Increasing Prevalence of Neonatal Jaundice
-
Growing Geriatric Population - The growing geriatric population is a significant demographic trend impacting various sectors, including healthcare and the phototherapy market. As populations age worldwide, there is a parallel increase in the prevalence of age-related health conditions, such as skin diseases and jaundice, which often necessitate medical interventions like phototherapy. Skin disorders like psoriasis, eczema, and vitiligo are known to become more common with age, presenting challenges for older adults seeking effective treatment options. Phototherapy emerges as a particularly valuable therapeutic approach for this demographic due to its non-invasive nature and proven efficacy in managing these dermatological conditions.
The geriatric population is also more susceptible to certain types of jaundice, such as obstructive jaundice, which can result from age-related changes in the liver and bile ducts. Neonatal jaundice, while most commonly associated with newborns, can also occur in older adults due to factors like liver dysfunction or medication side effects. Phototherapy serves as a vital intervention for managing jaundice in both neonates and older adults, offering a safe and effective means of reducing elevated bilirubin levels and preventing complications associated with jaundice.
In addition to skin disorders and jaundice, the geriatric population often experiences other age-related conditions that may benefit from phototherapy, such as chronic wounds, pruritus, and mood disorders like depression. Phototherapy has been shown to promote wound healing, alleviate itching, and improve mood by stimulating the production of endorphins and serotonin. As such, phototherapy holds promise as a holistic treatment modality for addressing the multifaceted healthcare needs of older adults, promoting both physical and psychological well-being.
Restraints :
- Stringent Regulatory Frameworks
- Reimbursement Issues
-
High Equipment Costs - High equipment costs represent a significant restraint in the global phototherapy market, posing challenges for healthcare providers, patients, and market players alike. Phototherapy devices, whether designed for dermatological treatments, neonatal jaundice management, or other medical applications, often require substantial upfront investment, making them financially burdensome for healthcare facilities, particularly those in resource-limited settings. The high cost of equipment can deter healthcare providers from investing in phototherapy technology, limiting access to these potentially life-saving interventions for patients in need.
The affordability of phototherapy treatments for patients is also impacted by high equipment costs. Healthcare facilities may pass on the expenses associated with acquiring and maintaining phototherapy devices to patients through higher treatment fees or out-of-pocket expenses, potentially creating barriers to access for individuals with limited financial resources. In regions where healthcare coverage is inadequate or where phototherapy is considered elective rather than essential, high equipment costs can exacerbate disparities in healthcare access and affordability.
For market players in the phototherapy industry, high equipment costs present challenges in terms of market penetration and competitive pricing. Companies may struggle to attract customers and expand their market share if their products are perceived as prohibitively expensive compared to alternatives or if they cannot demonstrate a clear return on investment for healthcare providers. Additionally, high equipment costs may deter innovation and research in the phototherapy sector, as companies prioritize cost containment and profitability over investing in the development of new technologies and treatment modalities.
Addressing the issue of high equipment costs in the phototherapy market requires collaboration among stakeholders to find sustainable solutions. This may involve initiatives to reduce manufacturing costs through technological advancements, streamline regulatory processes to expedite market entry for new products, and explore alternative financing models such as leasing or rental programs to make phototherapy equipment more accessible to healthcare providers. By addressing the affordability barrier associated with high equipment costs, the phototherapy market can better fulfill its potential to improve patient outcomes and enhance healthcare delivery worldwide.
Opportunities :
- Emerging Markets in Asia-Pacific and Latin America
- Technological Innovations and Advancements
- Strategic Collaborations and Partnerships
-
Increasing Demand for Non-Invasive Treatment Modalities - The increasing demand for non-invasive treatment modalities represents a significant opportunity in the global phototherapy market, driven by several key factors. Patients and healthcare providers alike are increasingly seeking alternatives to invasive procedures that carry greater risks, longer recovery times, and potential complications. Phototherapy emerges as a highly attractive option in this context, offering non-invasive treatments for a wide range of medical conditions, including dermatological disorders, neonatal jaundice, and mood disorders.
One of the primary drivers behind the demand for non-invasive treatment modalities is patient preference for safer and more comfortable treatment options. Phototherapy procedures typically involve exposing the skin to specific wavelengths of light, which penetrate the skin without the need for incisions or invasive techniques. This non-invasive approach reduces the risk of infection, scarring, and other complications commonly associated with surgical interventions, promoting faster recovery times and improved patient satisfaction.
The growing emphasis on preventive healthcare and wellness further fuels the demand for non-invasive treatment modalities like phototherapy. Patients are increasingly proactive about maintaining their health and addressing medical concerns at earlier stages, prompting a shift towards non-surgical interventions that offer effective outcomes with minimal disruption to daily life. Phototherapy aligns with this preventive healthcare ethos by providing treatments that are not only efficacious but also convenient and well-tolerated by patients.
Competitive Landscape Analysis
Key players in Global Phototherapy Market include :
- Beurer GmbH
- GE Healthcare
- Herbert Waldmann GmbH
- Koninklijke Philips N.V.
- Natus Medical Incorporated
- PhotoMedex Inc
- VIA Global Health
- Others
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Devices
- Market Snapshot, By Radiation
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Phototherapy Market Trends
- Drivers, Restraints and Opportunities
- Drivers
- Technological Advancements
- Rising Incidence of Skin Disorders
- Increasing Prevalence of Neonatal Jaundice
- Growing Geriatric Population
- Restraints
- Stringent Regulatory Frameworks
- Reimbursement Issues
- High Equipment Costs
- Opportunities
- Emerging Markets in Asia-Pacific and Latin America
- Technological Innovations and Advancements
- Strategic Collaborations and Partnerships
- Increasing Demand for Non-Invasive Treatment Modalities
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
-
Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Phototherapy Market, By Devices, 2021 - 2031 (USD Million)
- Firefly
- Fiber-Optic Blanket
- Fiber-Optic Band
- Others
- Global Phototherapy Market, By Radiation, 2021 - 2031 (USD Million)
- UVA
- UVB
- UVC
- Global Phototherapy Market, By Indication, 2021 - 2031 (USD Million)
- Skin Diseases
- Jaundice
- Others
- Global Phototherapy Market, By End User, 2021 - 2031 (USD Million)
- Hospitals & Clinics
- Dermatology Center
- Homecare
- Others
- Global Phototherapy Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia/New Zealand
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Phototherapy Market, By Devices, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Beurer GmbH
- GE Healthcare
- Herbert Waldmann GmbH
- Koninklijke Philips N.V.
- Natus Medical Incorporated
- PhotoMedex Inc
- VIA Global Health
- Others
- Company Profiles
- Analyst Views
- Future Outlook of the Market